Dilated Cardiomyopathy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy Intervention: Drug: Olmesartan 20 Mg Oral Tablet Sponsor: Dong-A University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2019 Category: Research Source Type: clinical trials
